E-MAIL CONTACT: INFO4POLBIOMED@GMAIL.COM

 Polbiomed LLC is a company providing services to its worldwide clients who are involved in biomedical research (both in animals and humans), as well as pharmaceutical and biochemical product inventors (during both pre-clinical and clinical phases of development). Our expertise ranges from board-certified and licensed medical practitioners with both clinical and pharmaceutical industry experience to scientists with significant experience in most modern molecular biology methods and proven-track of grant funding.

A brief look at our services

· Expertise in pharmacokinetic studies and analysis in both animals and humans

· Expertise in genomic/epigenomic data generation and bioinformatics (including DNA&RNA sequencing, microarray analysis, methylation assays)

· Expertise in pre-clinical pharmacology methods for wide-variety of conditions and models

· Experience in developing cell culture methods for variety of disease models

· Expertise in developing of clinical studies and analysis of large-sets of clinical data

Our state-of-the-art technology allows us to conduct any molecular testing with unparalleled precision and accuracy, leading to breakthrough discoveries and treatments.

Our team of experienced and highly trained researchers are dedicated to advancing the field of medicine and improving patient outcomes through innovative research.

We work closely with medical professionals, patients, and other organizations to ensure that our research is relevant, impactful, and aligned with the needs of the healthcare community.

All of our research is focused on improving patient outcomes and quality of life. We prioritize the needs and perspectives of patients in all aspects of our work.

We are at the forefront of cutting-edge research in a variety of areas, including cancer, infectious diseases, neurology, and more.

We are proud to partner with leading organizations in the medical research and development industry to advance the field and bring new treatments and technologies to patients around the world.